Project Grant HT94252310826
Award Date
9/30/23
Completion Date
9/29/26
Dollars Obligated
$605K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Houston, TX 77204, USA
Similar Awards
This Project Grant award, totaling $486,000.00, was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The award supports research conducted by the University of Texas MD Anderson Cancer Center, a component of the University of Texas System, to target PRMT5 in MTAP-loss melanoma. The project aims to transform health care for Service Members and the public through innovative and impactful cancer research, with a focus on...
This federal Project Grant award from the Defense Health Agency, under the Military Medical Research and Development (CFDA 12.420) program, provides $999,392.00 to the University of Houston System to conduct research on PRMT5 in lupus nephritis. The award commenced on September 1, 2025 and is set to conclude on August 31, 2029. The research aims to advance medical understanding and treatment of this condition, which is particularly relevant to military personnel and veterans. As a prominent...
The University of Houston System, a Hispanic-Serving Institution, was awarded a $1,101,840 federal Project Grant under the Department of Defense's Military Medical Research and Development program (CFDA 12.420). The grant, awarded on January 1, 2024, supports a research project titled "INVESTIGATING NEBIVOLOL IN TRIPLE-NEGATIVE BREAST CANCER" to be completed by December 31, 2026. The project aims to develop new treatments and advance scientific understanding of military health...
The University of Houston received a $299,787 Project Grant award from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund a research project from May 1, 2023 to April 30, 2025 to evaluate the diagnostic utility of antibodies to histone post-translational modifications in pediatric lupus patients. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with...
This federal Project Grant award, valued at $750,000.00, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The award supports research to investigate circulating immune complexes as potential biomarkers for the early detection and monitoring of ovarian cancer. The project will be performed by the University of Houston System, a Hispanic-Serving Institution, over a performance period from May 1, 2025 to April 30, 2029. This...
The University of Texas Health Science Center at Houston was awarded a $938,597 project grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) to conduct research on peptides targeting metastatic tumor cells as probes for cancer detection and vehicles for therapy delivery. The three-year award beginning September 1, 2022 will support the development of new biomedical technologies using metastatic tumor-targeting peptides to...
The University of Houston was awarded a $749,981 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research into the molecular basis of blood-brain barrier breach in lupus from May 1, 2023 through April 30, 2026. As part of the Military Medical Research and Development program's goals of transforming health care for service members and investigating medical solutions for the battlefield,...
The University of Texas Health Science Center at Houston was awarded a $1.25 million project grant from the Department of the Army Medical Command under the Military Medical Research and Development program to conduct research on peptides targeting metastatic tumor cells. The three-year award, made on September 1, 2022, will support the development of peptides as probes for cancer detection and delivery vehicles for cancer therapy. Through basic, applied, and advanced biomedical research, the...
The University of Texas MD Anderson Cancer Center, a component of the University of Texas System, received a $486,000 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The 3-year grant, with a start date of September 30, 2023, supports research targeting the PRMT5 protein in melanoma with MTAP gene loss. The funding will enable preclinical studies, including evaluating novel treatments, to advance the understanding and...
This $431,750 Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program will support research on the role of H19X noncoding RNAs in the pathogenesis of myotonic dystrophy type I. The grant was awarded to the University of Houston System, a public university system in Houston, Texas that serves as a Hispanic Serving Institution and comprehensive research university. The project will be conducted over a two-year...